Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: Findings from the RICA Registry

International Journal of Cardiology

Volumn 255, Issue , 2018, Pages 124-128

  Guisado Espartero, María Esther ^a   Salamanca Bautista, Prado ^b   Aramburu Bodas, Óscar ^b   Conde Martel, Alicia ^c   Arias Jiménez, José Luis ^b   Llàcer Iborra, Pau ^d   Dávila Ramos, Melitón Francisco ^e   Cabanes Hernández, Yolanda ^f   Manzano, Luis ^g   Montero Pérez Barquero, Manuel ^h  

^a HOSPITAL INFANTA MARGARITA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^d Hospital Manises   (Spain)

^e Consorcio Hospital General Universitario de Valencia ^*  (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Ejection fraction; Heart failure; Mortality, prognosis

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IVABRADINE; LOOP DIURETIC AGENT; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; ATRIAL FIBRILLATION; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FAILURE WITH MID RANGE EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INTERNAL MEDICINE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT PLANNING; CLINICAL TRIAL; COHORT ANALYSIS; EPIDEMIOLOGY; HEART STROKE VOLUME; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REGISTER; SPAIN; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEART FAILURE; HUMANS; INTERNAL MEDICINE; MALE; MORTALITY; PATIENT ADMISSION; PROSPECTIVE STUDIES; REGISTRIES; SPAIN; STROKE VOLUME;

EID: 85039769225     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.07.101     Document Type: Article

References (24)

1. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 62 (2013), e147–239.
2. Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 37 (2016), 2129–2200.
3. Álvarez-García, J., Salamanca-Bautista, P., Ferrero-Gregori, A., et al. Prognostic impact of physician specialty on the prognosis of outpatients with heart failure: propensity matched analysis of the REDINSCOR and RICA registries. Rev. Esp. Cardiol. (Engl Ed) 70 (2017), 347–354.
4. Registro Rica, Accessed July 7, 2017. Available from: https://www.registrorica.org.
5. Kapoor, J.R., Kappor, R., Ju, C., et al. Precipitating clinical factors, heart failure characterization and outcomes in patients hospitalized with heart failure with reduced, borderline and preserved ejection fraction. JACC Heart Fail. 4 (2016), 464–472.
6. Gómez-Otero, I., Ferrero-Gregori, A., Varela-Román, A., et al. Mid-range ejection fraction does not permit risk stratification among patients hospitalized for heart failure. Rev. Esp. Cardiol. (Engl Ed) 70 (2017), 338–346.
7. Rickenbacher, P., Kaufmann, B.A., Maeder, M.T., et al. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Eur. J. Heart Fail. 19:12 (2017), 1586–1596.
8. Pascual-Figal, D.A., Ferrero-Gregori, A., Gómez-Otero, I., et al. Mid-range left ventricular ejection fraction: clinical profile and cause of death in ambulatory patients with chronic heart failure. Int. J. Cardiol. 240 (2017), 265–270.
9. Chioncel, O., Lainscak, M., Seferovic, P.M., et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur. J. Heart Fail. 19:12 (2017), 1574–1585.
10. Coles, A.H., Tisminetzky, M., Yarzebski, J., et al. Magnitude of and prognostic factors associated with 1-year mortality after hospital discharge for acute decompensated heart failure based on ejection fraction findings. J. Am. Heart Assoc., 4, 2015, 10.1098/rsif.2015.0006.
11. Coles, A.H., Fisher, K., Darling, C., et al. Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. Am. J. Cardiol. 114 (2014), 862–868.
12. Nichols, G.A., Reynolds, K., Kimes, T.M., et al. Comparison of risk of re-hospitalization, all-cause mortality, and medical care resource utilization in patients with heart failure and preserved versus reduced ejection fraction. Am. J. Cardiol. 116 (2015), 1088–1092.
13. Löfman, I., Szummer, K., Dahlström, U., et al. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction. Eur. Heart Fail. 19:12 (2017), 1606–1614.
14. Lam, C.S., Teng, T.H., Understanding heart failure with mid-range ejection fraction. JACC Heart Fail. 4 (2016), 473–476.
15. Juillière, Y., Suty-Selton, C., Riant, E., et al. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure. Arch. Cardiovasc. Dis. 107 (2014), 21–32.
16. Hogg, K., McMurray, J., The treatment of heart failure with preserved ejection fraction (“diastolic heart failure”). Heart Fail. Rev. 11 (2006), 141–146.
17. Solomon, S.D., Claggett, B., Lewis, E.F., et al. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction. Eur. Heart J. 37 (2016), 455–462.
18. Tsuji, K., Sakata, Y., Nochioka, K., et al. Characterization of heart failure patients with mid-range left ventricular ejection fraction – a report from the CHART-2 study. Eur. Heart Fail. 19:10 (2017), 1258–1269.
19. Bhatia, R.S., Tu, J.V., Lee, D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med. 355 (2006), 260–269.
20. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC), The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur. Heart J. 33 (2012), 1750–1757.
21. Anther, S., Chan, W., Bozkurt, B., et al. Impact of non cardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J. Am. Coll. Cardiol. 59 (2012), 998–1005.
22. Cheng, R.K., Cox, M., Neely, M.L., et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the medicare population. Am. Heart J. 168 (2014), 721–730.
23. Tsao, C.W., Lyass, A., Larson, M.G., et al. Prognosis of adults with borderline left ventricular ejection fraction. JACC Heart Fail. 4 (2016), 502–510.
24. Nadruz, W. Jr., West, E., Santos, M., et al. Heart failure and midrange ejection fraction: implications of recovered ejection fraction for exercise tolerance and outcomes. Circ. Heart Fail., 9, 2016, e002826.